Latest Insider Transactions at Achieve Life Sciences, Inc. (ACHV)
This section provides a real-time view of insider transactions for Achieve Life Sciences, Inc. (ACHV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ACHIEVE LIFE SCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ACHIEVE LIFE SCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
John Bencich CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+1.08%
|
-
|
|
May 27
2021
|
John Bencich CEO |
BUY
Open market or private purchase
|
Direct |
6,000
+49.42%
|
$42,000
$7.0 P/Share
|
|
Jun 11
2019
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 11
2019
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
312,145
-2.03%
|
$936,435
$3.21 P/Share
|
|
Jun 11
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 11
2019
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,813
+1.23%
|
$38,439
$3.8 P/Share
|